RETRACTED ARTICLE: Downregulation of miR-196-5p Induced by Hypoxia Drives Tumorigenesis and Metastasis in Hepatocellular Carcinoma

[1]  Fuman Qiu,et al.  Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma. , 2016, Cancer letters.

[2]  Xin Zheng,et al.  miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4. , 2016, Cancer letters.

[3]  M. Ladanyi,et al.  Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma. , 2016, Cancer research.

[4]  D. Radisky,et al.  Tissue Stiffness and Hypoxia Modulate the Integrin-Linked Kinase ILK to Control Breast Cancer Stem-like Cells. , 2016, Cancer research.

[5]  Z. Cao,et al.  A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma. , 2016, Cancer research.

[6]  M. Iorio,et al.  miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer. , 2016, Cancer research.

[7]  Michael B. Stadler,et al.  miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer. , 2016, Cancer research.

[8]  Noam Shomron,et al.  Local microRNA delivery targets Palladin and prevents metastatic breast cancer , 2016, Nature Communications.

[9]  I. Landrieu,et al.  Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases , 2016, Nature Communications.

[10]  P. Lowenstein,et al.  Survival and Proliferation of Neural Progenitor–Derived Glioblastomas Under Hypoxic Stress is Controlled by a CXCL12/CXCR4 Autocrine-Positive Feedback Mechanism , 2016, Clinical Cancer Research.

[11]  Shu-Chun Lin,et al.  MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity. , 2016, Cancer research.

[12]  Kou-Juey Wu,et al.  miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3. , 2016, Cancer letters.

[13]  Prahlad T. Ram,et al.  Targeting KRas-dependent tumor growth, circulating tumor cells and metastasis in vivo by clinically significant miR-193a-3p , 2016, Oncogene.

[14]  Jianfei Xue,et al.  miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis. , 2016, Cancer research.

[15]  A. Harris,et al.  Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and Suppresses Tumor Growth. , 2016, Cancer research.

[16]  E. Rankin,et al.  Hypoxic control of metastasis , 2016, Science.

[17]  Qi Zhang,et al.  Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis. , 2016, Cancer research.

[18]  A. Azab,et al.  The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy , 2015, Hypoxia.

[19]  F. Martelli,et al.  Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210. , 2015, Cancer research.

[20]  T. Löning,et al.  HMGA2 expression distinguishes between different types of postpubertal testicular germ cell tumour , 2015, The journal of pathology. Clinical research.

[21]  N. Raulf,et al.  MicroRNA‐196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance , 2015, International journal of cancer.

[22]  H. Zwierzina,et al.  Abstract 316: Development of a novel 3D cancer model by cultivation of malignant effusions in a 3D cell culture system , 2015 .

[23]  K. McGlynn,et al.  Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. , 2015, Clinics in liver disease.

[24]  T. Ho,et al.  Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma. , 2015, Cancer research.

[25]  Yanping Zhang,et al.  MDM2-p53 pathway in hepatocellular carcinoma. , 2014, Cancer research.

[26]  T. Yen,et al.  OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway , 2014, Molecular Cancer.

[27]  Shuhan Sun,et al.  A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.

[28]  W. Cong,et al.  Perturbation of MicroRNA‐370/Lin‐28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma , 2013, Hepatology.

[29]  Shu-Chun Lin,et al.  miR-196a Overexpression and miR-196a2 Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas , 2013, Annals of Surgical Oncology.

[30]  K. Hwang,et al.  MicroRNAs as novel regulators of stem cell fate. , 2013, World journal of stem cells.

[31]  Sung-Chou Li,et al.  Aberrant expression of miR‐196a in gastric cancers and correlation with recurrence , 2012, Genes, chromosomes & cancer.

[32]  Ming Sun,et al.  MiR-196a Is Upregulated in Gastric Cancer and Promotes Cell Proliferation by Downregulating p27kip1 , 2012, Molecular Cancer Therapeutics.

[33]  Fang Wang,et al.  The histone deacetylase 4/SP1/microrna‐200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma , 2011, Hepatology.

[34]  A. Bosserhoff,et al.  MicroRNA miR‐196a controls melanoma‐associated genes by regulating HOX‐C8 expression , 2011, International journal of cancer.

[35]  Q. Yao,et al.  MicroRNA-196: critical roles and clinical applications in development and cancer , 2011, Journal of cellular and molecular medicine.

[36]  Shuang Huang,et al.  Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis. , 2010, Cancer research.

[37]  A. Bosserhoff,et al.  MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma , 2010, Cellular and Molecular Life Sciences.

[38]  J. Rowley,et al.  Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. , 2009, Blood.

[39]  J. Pouysségur,et al.  Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.

[40]  Chang-Zheng Chen,et al.  MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.

[41]  Patrick D. Sutphin,et al.  Coordinate Regulation of the Oxygen-Dependent Degradation Domains of Hypoxia-Inducible Factor 1α , 2005, Molecular and Cellular Biology.

[42]  Peter F Stadler,et al.  Evolution of microRNAs located within Hox gene clusters. , 2005, Journal of experimental zoology. Part B, Molecular and developmental evolution.

[43]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[44]  J. Brown,et al.  Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.

[45]  Kyu-Won Kim,et al.  Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functions , 2004, Experimental & Molecular Medicine.

[46]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[47]  R. Reeves,et al.  HMGI/Y proteins: flexible regulators of transcription and chromatin structure. , 2001, Biochimica et biophysica acta.

[48]  Herman Van den Berghe,et al.  Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours , 1995, Nature Genetics.

[49]  E. E. van der Wall,et al.  Molsidomine in the treatment of patients with angina pectoris. , 1980, The New England journal of medicine.

[50]  M. Iorio,et al.  Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers. , 2017, Cancer letters.

[51]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[52]  Shuang Huang,et al.  Ratio of miR-196 s to HOXC 8 mRNA Correlates with Breast Cancer Cell Migration and Metastasis , 2010 .